Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-10

Clinical Trial Update: Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety of three dose regimens of iron sucrose for Restless Legs Syndrome based on clinical assessments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron sucrose (iron sucrose)

Snippet

Sponsor: American Regent, Inc. | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-06-10